Low-Level Kanamycin Resistance in Mycobacterium tuberculosis: Molecular Mechanisms and Clinical Implications

Development of the tyrosine kinase inhibitor imatinib mesylate as a therapeutic for tuberculosis

Mycobacterial serine proteases and modulation of host immunity